Industry Bulletins | September 18, 2019
American Kidney Fund Announces Partnership With Janssen Pharmaceuticals, Inc. Focused On Reducing Chronic Kidney Disease In The U.S.
To address the enormous public health threat of kidney disease, the American Kidney Fund (AKF) announced a partnership with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to increase early detection and treatment of chronic kidney disease (CKD)—the fastest-growing noncommunicable disease—and help those at risk to prevent it altogether.
The overwhelming majority—96%—of people with early-stage kidney disease are not aware they have it, thereby lacking the knowledge and treatment that could help them slow down or stop its progression to kidney failure (end-stage renal disease, or ESRD). The . . .